Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 5/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | CCKBR | P32239 | 1/20 | 0.32 |
| ▸ | MAT2A | P31153 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Styrene SCHEMBL10628468 | 0.80 | ALDH1A1 (0.64) | TP53TDP1TSHRALDH1A1HDAC8 | |
| SCHEMBL2090802 | 0.79 | TSHR (0.39) | TSHRKCNH2APPMAT2A | |
| SCHEMBL2090801 | 0.79 | TSHR (0.39) | TSHRKCNH2APPMAT2A | |
| SCHEMBL95532 | 0.78 | ALDH1A1 (0.48) | TDP1TSHRALDH1A1PTGS2KCNH2 | |
| SCHEMBL14290425 | 0.78 | TSHR (0.42) | TP53TDP1TSHRALDH1A1MEN1 | |
| SCHEMBL9765849 | 0.78 | TDP1 (0.48) | TP53TDP1TSHRALDH1A1MEN1 | |
| SCHEMBL7024378 | 0.78 | TP53 (0.48) | TP53TDP1TSHRALDH1A1MEN1 | |
| SCHEMBL6653366 | 0.78 | TDP1 (0.48) | TP53TDP1TSHRALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL9789740 | 0.77 | TDP1 (0.47) | TP53TDP1TSHRALDH1A1MEN1 | |
| SCHEMBL22369239 | 0.77 | TSHR (0.41) | TSHRKCNH2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3456757-B1 | POLYIMIDE RESIN AND POLYIMIDE RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2023-06-07 | — | — | EP | disclosed |
| CN-109046463-B | Bidentate aza-carbene-manganese catalyst, preparation method and alkylation synthesis application thereof | 中山大学 | 2021-05-04 | — | — | CN | disclosed |
| CN-104880908-B | Photosensitive resin composition | 住友化学株式会社 | 2019-12-13 | — | — | CN | disclosed |
| EP-1761523-B1 | USE OF TRIAZINYL FLAVONATE BRIGHTENERS | BLANKOPHOR GMBH & CO KG (DE) | 2015-11-04 | — | — | EP | disclosed |
| US-7598009-B2 | Photosensitive resin composition, production method for cured relief pattern using it, and semiconductor device | FUJIFILM CORPORATION (JP) | 2009-10-06 | — | — | US | disclosed |
| US-20090035693-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR CURED RELIEF PATTERN USING IT, AND SEMICONDUCTOR DEVICE | FUJIFILM CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| US-7329660-B2 | Phthalazine derivatives for treating inflammatory diseases | NOVARTIS AG (CH) | 2008-02-12 | — | — | US | disclosed |
| US-7329660-B2 | Phthalazine derivatives for treating inflammatory diseases | NOVARTIS AG (CH) | 2008-02-12 | — | — | US | disclosed |
| WO-2004058234-A2 | PHARMACEUTICAL COMBINATIONS OF PHTHALAZINE VEGF INHIBITORS AND BENZAMIDE HDAC INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-07-15 | — | — | WO | disclosed |
| US-20030130510-A1 | Process for producing N-hydroxyalkyl compound, and tris (2-hydroxyethyl) isocyanurate composition | NIPPON SHOKUBAI CO., LTD. | 2003-07-10 | — | — | US | disclosed |
| EP-1323706-A1 | Process for producing N-hydroxyalkyl compound, and tris(2-hydroxyethyl) isocyanurate composition | Nippon Shokubai Co., Ltd. (JP) | 2003-07-02 | — | — | EP | disclosed |
| EP-0859284-A1 | Water-developable photosensitive composition and production process thereof | Nippon Paint Co., Ltd. (JP) | 1998-08-19 | — | — | EP | disclosed |
| US-5736298-A | COMPRISES A PARTICULATE POLYMER OF A CARBOXY-GROUP-CONTAINING-DIENE HAVING A CROSSLINKED STRUCTURE | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1998-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130510-A1 | Process for producing N-hydroxyalkyl compound, and tris (2-hydroxyethyl) isocyanurate composition | HAAO, ALKBH3, FTO | TP53 4299/4885TDP1 2009/4885TSHR 3929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.